Human Longevity, Inc. is a San Diego–based venture launched by Craig Venter, Robert Hariri and Peter Diamandis in 2013.
Its goal is to build the world's most comprehensive database on human genotypes and phenotypes, and then subject it to machine learning so that it can help develop new ways to fight diseases associated with aging.
[8] In November 2019, C. Thomas Caskey, professor of molecular & human genetics at the Baylor College of Medicine, joined the company as Chief Medical Officer.
[9] In January 2020, Human Longevity published a study in the journal Proceedings of the National Academy of Sciences (PNAS) that showed that by integrating whole-genome sequencing with advanced imaging and blood metabolites, clinicians identified adults at risk for key health conditions.
The program claims to combine the most advanced technologies with a dedicated medical team to help people achieve their healthiest and longest life.